Ovaj gen je član EGF-TM7 familije klase II sedam transmembranskih (7-TM) molekula. On je kodiran genskim klusterom na kratkoj ruci hromozoma 19. CD97 je glikoprotein koji je prisutan na površini aktiviranih leukocita. Njegov ekstracelularni region sadrži nekoliko N-terminalnih domena sličnih epidermalnom faktoru rasta, koji posreduju vezivanje njegovog liganda, faktora ubrzanja raspada (engl.decay accelerating factor) (DAF, CD55), regulatornog proteina komplementne kaskade. Prisustvo strukturnih osobina karakterističnih za proteine ekstracelularnog matriksa i transmembranske proteine sugeriše da ovaj receptor učestvuje u ćelijskoj adheziji i signalizaciji nakon aktivacije leukocita. Poznate su tri alternativno splajsovane varijante.[3]
Reference
↑Hamann J, Eichler W, Hamann D, Kerstens HM, Poddighe PJ, Hoovers JM, Hartmann E, Strauss M, van Lier RA (Sep 1995). „Expression cloning and chromosomal mapping of the leukocyte activation antigen CD97, a new seven-span transmembrane molecule of the secretion receptor superfamily with an unusual extracellular domain”. J Immunol155 (4): 1942–50. PMID7636245.
↑Hamann J, Hartmann E, van Lier RA (Sep 1996). „Structure of the human CD97 gene: exon shuffling has generated a new type of seven-span transmembrane molecule related to the secretin receptor superfamily”. Genomics32 (1): 144–7. DOI:10.1006/geno.1996.0092. PMID8786105.
Mustafa T, Klonisch T, Hombach-Klonisch S, Kehlen A, Schmutzler C, Koehrle J, Gimm O, Dralle H, Hoang-Vu C (February 2004). „Expression of CD97 and CD55 in human medullary thyroid carcinomas”. Int. J. Oncol.24 (2): 285–94. PMID14719104.
Mustafa T, Eckert A, Klonisch T, Kehlen A, Maurer P, Klintschar M, Erhuma M, Zschoyan R, Gimm O, Dralle H, Schubert J, Hoang-Vu C (January 2005). „Expression of the epidermal growth factor seven-transmembrane member CD97 correlates with grading and staging in human oral squamous cell carcinomas”. Cancer Epidemiol. Biomarkers Prev.14 (1): 108–19. PMID15668483.
Kwakkenbos MJ, Kop EN, Stacey M i dr.. (2004). „The EGF-TM7 family: a postgenomic view”. Immunogenetics55 (10): 655–66. DOI:10.1007/s00251-003-0625-2. PMID14647991.
Maruyama K, Sugano S (1994). „Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides”. Gene138 (1–2): 171–4. DOI:10.1016/0378-1119(94)90802-8. PMID8125298.
Gray JX, Haino M, Roth MJ i dr.. (1997). „CD97 is a processed, seven-transmembrane, heterodimeric receptor associated with inflammation”. J. Immunol.157 (12): 5438–47. PMID8955192.
Aust G, Eichler W, Laue S i dr.. (1997). „CD97: a dedifferentiation marker in human thyroid carcinomas”. Cancer Res.57 (9): 1798–806. PMID9135025.
Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K i dr.. (1997). „Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library”. Gene200 (1–2): 149–56. DOI:10.1016/S0378-1119(97)00411-3. PMID9373149.
Eichler W (2000). „CD97 isoform expression in leukocytes”. J. Leukoc. Biol.68 (4): 561–7. PMID11037979.
Lin HH, Stacey M, Saxby C i dr.. (2001). „Molecular analysis of the epidermal growth factor-like short consensus repeat domain-mediated protein-protein interactions: dissection of the CD97-CD55 complex”. J. Biol. Chem.276 (26): 24160–9. DOI:10.1074/jbc.M101770200. PMID11297558.
Visser L, de Vos AF, Hamann J i dr.. (2003). „Expression of the EGF-TM7 receptor CD97 and its ligand CD55 (DAF) in multiple sclerosis”. J. Neuroimmunol.132 (1–2): 156–63. DOI:10.1016/S0165-5728(02)00306-5. PMID12417446.
Stacey M, Chang GW, Davies JQ i dr.. (2003). „The epidermal growth factor-like domains of the human EMR2 receptor mediate cell attachment through chondroitin sulfate glycosaminoglycans”. Blood102 (8): 2916–24. DOI:10.1182/blood-2002-11-3540. PMID12829604.
Ota T, Suzuki Y, Nishikawa T i dr.. (2004). „Complete sequencing and characterization of 21,243 full-length human cDNAs”. Nat. Genet.36 (1): 40–5. DOI:10.1038/ng1285. PMID14702039.
Grimwood J, Gordon LA, Olsen A i dr.. (2004). „The DNA sequence and biology of human chromosome 19”. Nature428 (6982): 529–35. DOI:10.1038/nature02399. PMID15057824.